Differentials of SARS-CoV-2 Viral RNA Re-positivity in Discharged COVID-19 Patients

Clicks: 302
ID: 269878
2021
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #6 of 6 articles by views in aids reviews

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly infectious RNA coronavirus responsible for the pandemic of the coronavirus disease 2019 (COVID-19). Recent advances in virology, epidemiology, diagnosis, and clinical management of COVID-19 have contributed to the con …
Reference Key
j2021aidsdifferentials Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Xia J, Zeng Y, Tan Z, Chen T, Hu W, Shuai S, Cao D, Zeng X
Are you one of these authors? Claim your profile
Journal aids reviews
Year 2021
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/34082440
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE pubmed abstract nih national institutes of health national library of medicine pmid:34082440 doi:10.24875/aidsrev.21000023 jiliang xia ying zeng xi zeng

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.